BioSpace1d
Leqembi, Kisunla and Beyond: The Next Wave of Alzheimer’s at CTAD 2024
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
Trade Arabia5d
Lilly collaborates with top Saudi hospital on Alzheimer’s early detection tests
King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limited (Lilly) have signed a ...
中国日报网4d
Eli Lilly brings Memory Cafe to CIIE to raise public awareness about Alzheimer's disease
US pharmaceutical company Eli Lilly brings Memory Cafe to its booth at the ongoing 7th CIIE in collaboration with the ...
Zawya5d
Lilly collaborates with top Saudi hospital on manufacturing alzheimer’s early detection tests
Riyadh: The signing of a Memorandum of Understanding (MoU) between King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limited (Lilly) would pave the way to transform ...
Hosted on MSN15h
Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?
The stock of Eli Lilly and Company LLY has declined 10.6% in a month ... Lilly is also making rapid pipeline progress in ...
alzheimersnewstoday3d
Modified Kisunla dosing shown to lower risk of ARIA-E in Alzheimer’s
Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E on imaging scans.
Ibj.com4d
Lilly CEO Dave Ricks named Watanabe Award winner
Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...
GEN6d
Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.